Acute Myeloid Leukemia | Proceedings from a live event held in conjunction with the 2021 Pan Pacific Lymphoma Conference

Featuring perspectives from Drs Krishna Gundabolu, Richard M Stone and Eunice S Wang, moderated by Dr Harry Paul Erba, including the following topics:   Introduction (00:00) Case: A man in his late 60s with acute myeloid leukemia (AML) and an IDH2 mutation — Wendy Stock, MD (01:13) Case: A man in his early 80s with AML and multiple comorbidities who receives up-front venetoclax and azacitidine — Mark Levis, MD, PhD (06:00) Management of newly diagnosed AML in patients ineligible for intensive induction therapy (12:22) Case: A man in his early 70s with newly diagnosed AML with poor prognostic features — Dr Levis (21:36) Case: A woman in her late teens with AML and complex cytogenetics — Dr Stock (25:56) Treatment of AML in adult patients eligible for intensive therapy (30:48) Case: A man in his late 40s with newly diagnosed AML with poor prognostic features — Dr Levis (43:06) Case: A man in his late 70s with AML and FLT3 and IDH2 mutations — Dr Stock (46:24) Clinical decision-making for patients diagnosed with AML and an actionable mutation (54:27) Case: A man in his late 60s with transfusion-dependent myelodysplastic syndrome with ringed sideroblasts — Dr Stock (01:05:24) Current and future treatment considerations for patients with myelodysplastic syndromes (01:11:33)   CME information and select publications